Searchable abstracts of presentations at key conferences in endocrinology

ea0007p96 | Endocrine tumours and neoplasia | BES2004

Results of different primary treatment procedures for acromegalic patients

Ozbey N , Gjergji D , Sertkaya A , Kurt R , Molvalilar S

In this study 32 acromegalic patients were retrospectively evaluated with respect to the results of different primary treatment procedures. Study group was composed of 32 acromegalic patients admitted to our department between the years 1979-2002 (20 females, 12 males; mean age 45.2 plus/minus 14.3 years, mean follow-up: 80.7 plus/minus 62.9 months). Patients were grouped according to the primary treatment approach: 1) Patients underwent pituitary surgery (n: 28; 21 macroadeno...

ea0004p76 | Reproduction | SFE2002

Metformin and weight loss in women with polycystic ovary syndrome (PCOS)

Harborne L , Sattar N , Lyall H , Norman J , Fleming R

Metformin treatment of women with PCOS has been shown to improve ovarian function, reduce hyperandrogenicity and induce weight loss. The aim of this prospective study was to investigate the nature of the weight loss in obese women with PCOS, using 2 dose regimes.Methods: Obese (body mass index [BMI] > 29 kilograms /m2) women with PCOS (n = 44) were recruited to the study, and randomised to receive either 1500mg metformin daily (n = 22), or ...

ea0075d17 | Diabetes | EYES2021

Efficiency of glucocorticosteroids in combination with biological therapy in patients with type 2 diabetes mellitus and new coronavirus infection

Ponomareva Anastasia , Markova Tatyana N. , Samsonova Inna V.

Aim: To evaluate the efficiency of glucocorticosteroids (GCS) in combination with biological therapy in the treatment of COVID-19 in patients with type 2 diabetes mellitus (T2D).Materials and methods: A retrospective study of hospitalized patients with a PCR-confirmed diagnosis of COVID-19 with T2D was conducted (n=179). Patients received standard therapy, including biological preparations. The first group consisted of participants who received ...

ea0007p219 | Steroids | BES2004

Hexose 6-phosphate dehydrogenase expression confers reductase activity upon 11 beta-HSD1 in adipose tissue

Bujalska I , Tomlinson J , Draper N , Walker E , Stewart P

Glucocorticoids are an important adipogenic factor. In man, circulating cortisol excess causes visceral obesity, but in simple obesity glucocorticoid levels are usually normal. However, in adipose tissue cortisol availability to bind to the glucocorticoid receptor (GR) is modulated by 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1). Human preadipocytes display both dehydrogenase (cortisol to cortisone) and oxo-reductase (cortisone to cortisol) activity. Recent genet...

ea0029p210 | Calcium & Vitamin D metabolism | ICEECE2012

Longitudinal changes in serum 25-hydroxyvitamin D levels of older persons during 6 and 13 years of follow-up

van Schoor N. , Knol D. , Deeg D. , Heijboer A. , Lips P.

Background: Vitamin D deficiency is very common in older persons. It is not clear how serum 25-hydroxyvitamin D (25(OH)D) levels change during aging.Objective: To examine longitudinal changes in serum 25(OH)D levels in two representative cohorts of Dutch older persons during 6 and 13 years of follow-up, respectively.Methods: Data of the Longitudinal Aging Study Amsterdam (LASA) were used, an ongoing cohort study in older persons. T...

ea0010p73 | Reproduction | SFE2005

Serum concentrations of anti-mullerian hormone (AMH) and inhibin b, in regularly cycling and anovulatory women with polycystic ovaries (PCO)

Al-Qahtani A , Groome N , Themmen A , Goh M , Franks S

Recent studies have shown that serum concentrations of AMH (produced by granulosa cells of the human ovary) are positively related to the number of antral follicles and are negatively correlated with age. Like inhibin B (also a granulosa cell product) AMH is thought to be a useful clinical marker of follicle reserve. Serum AMH concentrations have been reported to be higher than normal in women with polycystic ovary syndrome (PCOS), which is characterised by an excess of antral...

ea0007oc26 | Endocrine tumours | BES2004

Mechanisms of HER2 resistance in endocrine tumours

Myers E , Hill A , McDermott E , O'Higgins N , Young L

Introduction: Regulation of HER2 through the transcription factor PEA3 is associated with tumour progression and resistance to endocrine treatment in human breast cancer. The mechanism of this resistance remains unclear. Activation of estrogen receptor co-activator proteins via the MAP-kinase pathway is thought to be central to tamoxifen insensitivity. We hypothesised that activation of HER2 by PEA3 may result in activation of co-activator proteins such as AIB1 (amplified-in-b...

ea0007p94 | Endocrine tumours and neoplasia | BES2004

Somatostatin and VEGF expression within the larynx

Bedford K , MacDonald A , Condon L , Stafford N , Atkin S

IntroductionSomatostatin has antiproliferative, anti-angiogenic and pro-apoptotic actions through 5 G-protein receptors (Sstr). In view of the anti-angiogenic effects of Sstrs their relationship to the distribution of vascular endothelial growth factor (VEGF) was undertaken in non-malignant Reinke's Oedema of the larynx and squamous cell carcinoma of the larynx.MethodsSix Reinke's oedema (non malignant) and 1...

ea0007p161 | Neuroendocrinology and behaviour | BES2004

The acute octreotide suppression test is useful in predicting long-term responses to depot somatostatin analogue injections in patients with active acromegaly

Botusan I , Karavitaki N , Radian S , Turner H , Wass J

Background: Long-acting depot somatostatin analogues injections are useful drugs in the medical treatment of acromegaly. No previous study has assessed the value of acute octreotide suppression test in predicting responses to depot injections.Objective: The aim of this study was to investigate the value of the acute octreotide suppression test (100 micrograms subcutaneously, GH measurements hourly for 8 hours) in predicting the long-term response to long...

ea0003p242 | Signalling | BES2002

Essential role of p38 mitogen-activated protein kinase in adipogenesis

Patel N , Holder J , Smith S , Kumar S , Eggo M

Human obesity is characterised by an increase in both the number of adipocytes and by an increase in their size, which is determined by adipogenesis. Adipogenesis can be induced in vitro in preadipocytes cultured in differentiation medium containing 3-isobutyl-1-methylxanthine, insulin, dexamethasone, and triiodothyronine but the signalling pathways important in adipogenesis are not well characterised. The p38 mitogen-activated protein kinase (MAPK) signalling pathway i...